BUSINESS BRIEF
A Mumbai-based cold chain transportation company focused on pharmaceutical logistics is seeking a strategic investor / sell-side transaction to accelerate expansion and scale operations.
Key Investment Highlights:
• 500+ clients across industries
• Premium pharma client base
• 30% CAGR revenue growth (9 years)
• 150 owned vehicle fleet
• Pan-India operations
• No client concentration risk
• RoCE > 20%
• RoE > 30%
• 13+ years operating history
• Low debt (<₹15 Cr)
Products & Services
Cold chain transportation services including temperature-controlled pharma logistics, full truck load (FTL) transportation, primary and secondary distribution, intercity and regional logistics, and pan-India refrigerated fleet operations.
Proposal
Industry
Transportation/Logistics
Sub Industry
Truck Transportation and Services (Road freight services) & Logistics (Cold Chain Logistics)
Nature of Business
B2B, B2G
Sector
Services
Reason for sell-off
Strategic Realignment or Pursuing New Opportunities
Location
India
Region
Western
Open For Dilution
100 % (Complete Buyout)
Top Customer
Deal Size
INR 120 - 125 Cr
Justification
Strong growth trajectory with revenue crossing ₹75 Cr in FY26, supported by premium pharmaceutical clientele ensuring stable and recurring business. Additionally, 30% revenue from hired vehicles reflects an asset-light, scalable model, strengthening the company’s valuation potential.
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
57.5 | 43.9 | 31.6 |
EBITDA |
|||
PAT |
